DE3372967D1 - Antihypercholesterolemic compounds - Google Patents

Antihypercholesterolemic compounds

Info

Publication number
DE3372967D1
DE3372967D1 DE8383112563T DE3372967T DE3372967D1 DE 3372967 D1 DE3372967 D1 DE 3372967D1 DE 8383112563 T DE8383112563 T DE 8383112563T DE 3372967 T DE3372967 T DE 3372967T DE 3372967 D1 DE3372967 D1 DE 3372967D1
Authority
DE
Germany
Prior art keywords
antihypercholesterolemic compounds
antihypercholesterolemic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383112563T
Other languages
English (en)
Inventor
William F Hoffman
Ta-Jyh Lee
Robert L Smith
Alvin K Willard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE3372967D1 publication Critical patent/DE3372967D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8383112563T 1982-12-22 1983-12-14 Antihypercholesterolemic compounds Expired DE3372967D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/452,176 US4472426A (en) 1982-12-22 1982-12-22 Antihypercholesterolemic compounds

Publications (1)

Publication Number Publication Date
DE3372967D1 true DE3372967D1 (en) 1987-09-17

Family

ID=23795386

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383112563T Expired DE3372967D1 (en) 1982-12-22 1983-12-14 Antihypercholesterolemic compounds

Country Status (4)

Country Link
US (1) US4472426A (de)
EP (1) EP0113881B1 (de)
JP (1) JPS59130249A (de)
DE (1) DE3372967D1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588715A (en) * 1984-06-04 1986-05-13 Sandoz, Inc. Heptenoic acid derivatives
KR910003427B1 (ko) * 1984-12-04 1991-05-31 산도즈 파마슈티칼스 코포레이션 메발로노락톤의 인덴동족체 및 이들의 유도체의 제법
US5208258A (en) * 1985-10-11 1993-05-04 The Regents Of The University Of California Antihypercholesterolemic compounds and synthesis thereof
US4950775A (en) * 1985-10-11 1990-08-21 University Of California Antihypercholesterolemic compounds and synthesis thereof
US4851427A (en) * 1985-10-25 1989-07-25 Sandoz Pharm. Corp. Pyrrole analogs of mevalonolactone, derivatives thereof and pharmaceutical use
JP2007323701A (ja) * 2006-05-30 2007-12-13 Mitsumi Electric Co Ltd 磁気テープ記録再生装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294846A (en) * 1979-09-21 1981-10-13 Merck & Co., Inc. Hypocholesteremic fermentation products and products of preparation
US4293496A (en) * 1980-02-04 1981-10-06 Merck & Co., Inc. 6(R)-[2-(8-Hydroxy-2,6-dimethylpolyhydronaphthyl-1)-ethyl]-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-ones
JPH0692381B2 (ja) * 1980-03-31 1994-11-16 三共株式会社 Ｍｂ−５３０ａ誘導体
JPS56150037A (en) * 1980-04-22 1981-11-20 Sankyo Co Ltd Hydronaphthalene compound
US4343814A (en) * 1980-11-17 1982-08-10 Merck & Co., Inc. Hypocholesterolemic fermentation products
DE3126083A1 (de) * 1981-07-02 1983-01-20 Basf Ag, 6700 Ludwigshafen N-substituierte 2-methylnaphthylamide, verfahren zu ihrer herstellung und diese enthaltende fungizide
JPS5835144A (ja) * 1981-08-27 1983-03-01 Sankyo Co Ltd Ｍｂ−５３０ｂ誘導体およびその製造法
JPS5855443A (ja) * 1981-09-25 1983-04-01 Sankyo Co Ltd オクタヒドロナフタリン誘導体およびその製造法
AU9133682A (en) * 1981-12-23 1983-06-30 Akira Endo Dihydro- and tetrahydromonacolin l- and their salts and esters

Also Published As

Publication number Publication date
JPS59130249A (ja) 1984-07-26
EP0113881A1 (de) 1984-07-25
US4472426A (en) 1984-09-18
JPH0419223B2 (de) 1992-03-30
EP0113881B1 (de) 1987-08-12

Similar Documents

Publication Publication Date Title
GB2128984B (en) Diaza-bicyclic compounds
GB2120248B (en) Polypiperidine compounds
ZA832431B (en) Active compounds
GB8301981D0 (en) Compounds
ZA831912B (en) Novel compounds
PT77860B (en) Compounds
DE3362221D1 (en) Azolylstyryl compounds
PH20022A (en) 7-substituted-3-vinyl-3-cephem compounds
GB2119368B (en) Substituted thiopyranopyrimidine compounds
GB8302397D0 (en) Perfluorobicyclo compounds
GB2128200B (en) Chloro-triazinyl mondazo compounds
DE3364273D1 (en) Dioxocyclobutene compounds
ZA839478B (en) Aralkyltriazole compounds
DE3372967D1 (en) Antihypercholesterolemic compounds
PH20433A (en) Phenothiazine compounds
PT77287B (en) Compound
ZA83691B (en) Novel benzapyran compounds
GB2117769B (en) Substituted diamino-thiadiazoles
GB8323641D0 (en) Substituted 1-pyridyloxy-3-indolylalkyl-amino-2-propanols
GB8318467D0 (en) Compounds
IE821622L (en) Condenser
GB8318978D0 (en) Aminoimidazolyl compounds
GB8330789D0 (en) Phthalidylammonium compounds
GB8302736D0 (en) Perfluoro-spiro compound
EG16401A (en) Novel oxime-phosphate compounds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee